跳至主要内容
临床试验/NCT04771585
NCT04771585已完成不适用

Quantification of Exhaled Particles to Identify Airborne Transmission Risks of SARS-Co-V-2

Fraunhofer-Institute of Toxicology and Experimental Medicine2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年3月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
To compare the emitted small particle fraction between various respiratory activities.

研究概览

简要总结

In this study, the aerosols emitted during various respiratory activities will be quantified in healthy subjects. The differences in aerosol size spectrum and number during tidal breathing, speaking, coughing and singing will be assessed. Subjects with an endogenously high aerosol emission will repeat the respiratory activities wearing face masks with varying particle filter capacity to investigate the aerosol emission reduction.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able and willing to give written informed consent.
  • Healthy male and female subjects, aged 18-80 years.
  • Body mass index between 18 and 35 kg/m
  • FEV1 ≥ 80% predicted.

排除标准

  • Any clinically relevant abnormal findings in physical examination or lung function at screening visit, which, in the opinion of the investigator, may either put the subject at risk because of participation in the study or may influence the results of the study, or the subject's ability to participate in the study.
  • Risk of non-compliance with study procedures.
  • Suspected inability to understand the protocol requirements, instructions and study-related restrictions, the nature, scope, and possible consequences of the study.
  • History of an acute respiratory infection with symptoms such as cough, rhinitis, sore throat, hoarseness or fever, within four weeks prior to the informed consent visit. In case of acute respiratory infection during study participation, the visit may be rescheduled within the allowed time window. Subjects must be asymptomatic for at least 3 days. Re-screening is allowed should the time window be exceeded.
  • History of lung disease including but not confined to COPD, asthma or pulmonary fibrosis.
  • History of latex allergy.

结局指标

主要结局

To compare the emitted small particle fraction between various respiratory activities.

时间窗: Day 1, Day 2 to 14

Change of particle number per time unit between tidal breathing and various respiratory activities.

To assess the influence of different face masks on the emitted small particle fraction of various respiratory activities.

时间窗: After completion of Study part A (approximately 3 months)

Change of particle number per time unit between tidal breathing and selected respiratory activities for community masks, surgical masks, FFP2 and FFP3 respirators in high-emitting subjects.

次要结局

  • To assess the influence of different face masks on the emitted particle size distribution of various respiratory activities.(After completion of Study part A (approximately 3 months))
  • To assess the emitted particle size distribution of various respiratory activities.(Day 1, Day 2 to 14)
  • To assess the reproducibility of exhaled particle quantification.(Day 2 to 14)

研究者

发起方
Fraunhofer-Institute of Toxicology and Experimental Medicine
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验